Abstract:Background: Mumps is caused by the mumps virus and is characterized by pain and parotid gland swelling. Although its incidence has declined due to vaccines, outbreaks still occur among children. In addition, it can lead to severe complications, so it has a certain perniciousness. Pudilan Xiaoyan oral liquid (PDL), a Chinese patent medicine, commonly treats children with mumps. However, its safety, efficacy, and specific mechanisms lack relevant evaluation and analysis. Therefore, we did a meta-analysis of the randomized controlled trials combined with a network pharmacology analysis to assess the efficacy and safety of PDL in relieving symptoms of mumps in children and investigate its pharmacological mechanisms. Methods: This study systematically searched the China National Knowledge Infrastructure (CNKI), WanFang Data Knowledge Service Platform, VIP Database, Sinomed, Chinese Medical Journal Full-text Database, PubMed, Embase, Cochrane Library, Web of Science, and Google Scholar for the published randomized controlled trials (date up to 3 March 2022; studies in both English and Chinese) comparing PDL and antiviral drug combination treatment to standalone antiviral drug treatment. The primary outcomes in this study were the effective rate and duration of five characteristic symptoms of children’s mumps. We assessed the pooled data by using a fix-effect or random-effect model. We illustrated an odds ratio (OR) or standardized mean difference (SMD) with a 95% confidence interval (CI) using the Stata 15 software. In network pharmacology, active components of PDL were collected from the traditional Chinese medicine system pharmacology technology platform and the CNKI studies, while mumps’ targets were collected from databases of the Genecards and Online Mendelian Inheritance in Man (OMIM), and then we constructed a “drug-component-target” network and a protein–protein interaction network using Cytoscape 3.9.0 for screening the core components and targets. Next, we ran Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of intersection targets of PDL and mumps. Finally, molecular docking was performed between core components and targets. Results: Of 70 identified studies, 12 were eligible and included in our analysis (N = 1,307 participants). Compared with the antiviral drug treatments, combination treatment using PDL and antiviral drugs provided higher effective rates (OR = 5.94), shorter symptom durations for fever (SMD = −1.05), headache (SMD = −0.69), parotid gland swelling (SMD = −1.30), parotid gland pain (SMD = −2.53), and loss of appetite (SMD = −0.56) with fewer reported side effects. Of the 113 active components of PDL and 57 mumps’ targets, 11 core components like quercetin, isoetin, and seven core targets such as albumin (ALB) and interleukin-6 were obtained. Moreover, the potential pathways identified included cytokine–cytokine receptor interaction and T helper cell 17 (Th17 cell) differentiation. Molecular docking results revealed that most core components and targets could form stable structures. The core components, including isoetin, quercetin, and luteolin, and core targets involving heat shock protein HSP 90-alpha (HSP90AA1), estrogen receptor (ESR1), and ALB showed the best affinities. Conclusion: The combined use of PDL and antiviral drugs could effectively improve the efficacy of mumps among children and rapidly alleviate mumps-related symptoms. This efficacy may be associated with the anti-inflammatory and antiviral mechanisms by which PDL acts using multiple components, multiple targets, and multiple pathways. However, these results should be confirmed by further studies.

[Analysis on origin and evolution of mumps]

Molecular biology, pathogenesis and pathology of mumps virus

Survey and analysis of 197 cases of mumps in a primary school in Xi’ an

[Understanding of Smallpox in Ancient China]

Analysis on pathogenic characteristics and genotype of mumps virus strain circulating in Beijing from 2004 to 2007

Epidemiological characteristics of mumps in Haidian district,Beijing,2005-2012

Epidemiological characteristics and interrupted time series analysis of mumps in Quzhou City, 2005–2023

Establishment of an Efficient Reverse Genetic System of Mumps Virus S79 from Cloned DNA

Acupuncture for Mumps in Children

Understanding Mumps Dynamics: Epidemiological Traits and Breakthrough Infections in the Population under 15 Years of Age in Jiangsu Province, China, 2023

Epidemiological characteristics and serological survey of mumps 15 years after MMR vaccine was included in the immunization program

Mumps Orchitis: Clinical Aspects and Mechanisms

Epidemic Characteristics Analysis of Mumps in Jiangxi Province During 2004～2005

Estimating the Transmissibility of Mumps: A Modelling Study in Wuhan City, China

[Genetic characterization of wild-type mumps virus isolated in Liaoning Province]

[Research on the origin and development of "Wu shan qi e"]

Analysis on genotype of mumps virus strain circulating in Beijing city

Genomic Characterization of Three Canadian Mumps Outbreaks Demonstrates Endemic Transmission in Canada

Knowledge gaps persist and hinder progress in eliminating mumps

Clinical efficacy evaluation and potential mechanism prediction on Pudilan Xiaoyan oral liquid in treatment of mumps in children based on meta-analysis, network pharmacology, and molecular docking

Identification and development of a promising novel mumps vaccine candidate strain